Associations of sleep duration, sedentary behaviours and energy expenditure with maternal glycemia in pregnancy.


Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
01 2020
Historique:
received: 21 03 2019
revised: 09 07 2019
accepted: 12 07 2019
pubmed: 12 11 2019
medline: 27 10 2020
entrez: 12 11 2019
Statut: ppublish

Résumé

Women with high levels of physical activity (PA) are less likely to develop gestational diabetes mellitus (GDM), but the relations with sleep and sedentary behaviours (SB) are more controversial. We aimed to investigate all three components (sleep, PA, and SB) and their association with maternal glucose in pregnancy. We included 766 pregnant women recruited at first trimester and that we followed at second trimester. We collected blood samples, anthropometry and standardized questionnaires about lifestyle including PA, SB, and sleep duration at both visits. Women completed a 50 g glucose challenge test at first trimester and 75-g oral glucose tolerance test (OGTT) at second trimester. We conducted regression analyses to test cross-sectional associations between sleep, PA, and SB with maternal glucose levels while taking into account potential confounders (maternal age, pre-pregnancy body mass index (BMI), gravidity, and smoking). We considered linear and quadratic relationships. At first trimester, we observed a linear relationship between shorter sleep duration and higher glucose levels, which was attenuated after adjustments for confounders. At second trimester, we found a quadratic relationship between sleep and glucose showing lowest levels at fasting and 1 h-post OGTT for women who slept 6-10 h/night. This association remained significant after adjusting for confounders and taking into account PA and/or SB. Greater amount of SB was associated with higher 1 h-glucose after adjustment for confounders (β = 0.132; SE = 0.047; P = 0.005). Sleep duration is associated with glucose regulation in pregnancy, independently of PA and SB, and this association varies according to the period of gestation.

Sections du résumé

BACKGROUND
Women with high levels of physical activity (PA) are less likely to develop gestational diabetes mellitus (GDM), but the relations with sleep and sedentary behaviours (SB) are more controversial. We aimed to investigate all three components (sleep, PA, and SB) and their association with maternal glucose in pregnancy.
METHODS
We included 766 pregnant women recruited at first trimester and that we followed at second trimester. We collected blood samples, anthropometry and standardized questionnaires about lifestyle including PA, SB, and sleep duration at both visits. Women completed a 50 g glucose challenge test at first trimester and 75-g oral glucose tolerance test (OGTT) at second trimester. We conducted regression analyses to test cross-sectional associations between sleep, PA, and SB with maternal glucose levels while taking into account potential confounders (maternal age, pre-pregnancy body mass index (BMI), gravidity, and smoking). We considered linear and quadratic relationships.
RESULTS
At first trimester, we observed a linear relationship between shorter sleep duration and higher glucose levels, which was attenuated after adjustments for confounders. At second trimester, we found a quadratic relationship between sleep and glucose showing lowest levels at fasting and 1 h-post OGTT for women who slept 6-10 h/night. This association remained significant after adjusting for confounders and taking into account PA and/or SB. Greater amount of SB was associated with higher 1 h-glucose after adjustment for confounders (β = 0.132; SE = 0.047; P = 0.005).
CONCLUSIONS
Sleep duration is associated with glucose regulation in pregnancy, independently of PA and SB, and this association varies according to the period of gestation.

Identifiants

pubmed: 31710875
pii: S1389-9457(19)30245-X
doi: 10.1016/j.sleep.2019.07.008
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-61

Subventions

Organisme : CIHR
ID : MOP 115071
Pays : Canada
Organisme : CIHR
ID : MOP 152989
Pays : Canada

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Myriam Doyon (M)

Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, 3001 12(e) Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada.

Laura Pelland-St-Pierre (L)

Département de Médecine, Service d'endocrinologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, 3001 12(e) Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada.

Catherine Allard (C)

Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, 3001 12(e) Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada.

Luigi Bouchard (L)

Département de Biochimie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, 3001 12(e) Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada; Département de Biologie Médicale, CIUSSS du Saguenay-Lac-Saint-Jean, 305 Rue Saint-Vallier, Chicoutimi, QC, G7H 5H6, Canada.

Patrice Perron (P)

Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, 3001 12(e) Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada; Département de Médecine, Service d'endocrinologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, 3001 12(e) Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada.

Marie-France Hivert (MF)

Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, 3001 12(e) Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada; Département de Médecine, Service d'endocrinologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, 3001 12(e) Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, 133 Brookline Avenue, Boston, MA, 02215, USA; Diabetes Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. Electronic address: mhivert@partners.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH